insights_auto
Why is VRAX down 2.68%?
Dive Deeperchevron_right
VRAX:NASDAQ
Virax Biolabs Group Ltd
$2.18
arrow_downward
-2.68%(-0.060) 1D
$2.62
arrow_upward
+20.18% (+0.44)todayPre-market
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRAX...
Open
$2.21
High
$2.25
Low
$2.13
Mkt. cap
2.89M
Avg. vol.
57.49K
Volume
87.49K
52-wk high
$21.75
52-wk low
$2.05
EPS
-$12.64
Beta
1.40
Shares outstanding
1.34M
No. of employees
26
Open
$2.21
High
$2.25
Low
$2.13
Mkt. cap
2.89M
Avg. vol.
57.49K
Volume
87.49K
52-wk high
$21.75
52-wk low
$2.05
EPS
-$12.64
Beta
1.40
Shares outstanding
1.34M
No. of employees
26
News stories
From web sources and news partners
Quartz
·
13 minutes ago
Dow futures slip as Treasury yields stay high Monday
bloomingbit
·
28 minutes ago
US Corporate Profit Run Continues as S&P 500 Q3 Net Income Estimate Rises 2.2%
Barron's
·
20 minutes ago
S&P 500 Futures Decline in Premarket Trading; Vaxcyte, PTC Lead
www.marketscreener.com
·
5 hours ago
Panmure Liberum sets 2027 year-end S&P 500 target at 5,000
About Virax Biolabs Group Ltd
CEO-
Employees26
Founded2013
HeadquartersLondon, England, United Kingdom
SectorHealth care provider
Websiteviraxbiolabs.com